AB0088 Transgenic ZAP-70+ B Cells Mice Show A More Severe Collagen Antibody Induced Arthritis (CAIA) than Wild Type. (15th July 2016)
- Record Type:
- Journal Article
- Title:
- AB0088 Transgenic ZAP-70+ B Cells Mice Show A More Severe Collagen Antibody Induced Arthritis (CAIA) than Wild Type. (15th July 2016)
- Main Title:
- AB0088 Transgenic ZAP-70+ B Cells Mice Show A More Severe Collagen Antibody Induced Arthritis (CAIA) than Wild Type
- Authors:
- Biscetti, F.
Angelini, F.
Gobessi, S.
Gremese, E.
Tolusso, B.
Efremov, D.
Ferraccioli, G. - Abstract:
- Abstract : Background: Zeta-chain-associated protein kinase 70 (ZAP-70), a tyrosine kinase constitutively expressed in T cells, can be found in B cells and is used as a prognostic marker in identifying different forms of chronic lymphocytic leukemia. We previously provided evidence that a subset of B cells in patients with rheumatoid arthritis (RA) expresses ZAP-70, that marks the memory B cell subsets (IgD+CD27+ and IgD-CD27+), thus suggesting that the ZAP-70+ B cells represent a memory activated subset likely involved in the maintenance of an activated B cell pool [1–3]. Objectives: The aim of the present study was to clarify whether B cells, especially ZAP-70 expressing B cells, represent indeed a risk for a severe expression of arthritis in a transgenic ZAP-70+B murine model. Methods: Male transgenic ZAP-70+B mice, that has already been shown to present an high ZAP-70 expression in the B cell lineage [4], aged 8–12 weeks old were used for experiments. All the animals were injected with a cocktail of 5 monoclonal antibodies recognizing the conserved epitopes on various species of type II collagen. Three days later the mice were injected with LPS from E. coli 0111:B4 to trigger arthritis development. Animals were evaluated every 3 days after the infusion of the antibody cocktail for arthritis incidence and each paw was evaluated and scored individually on a scale of 0–4. An arthritis index (AI) that expressed a cumulative score for all paws was calculated for each animal.Abstract : Background: Zeta-chain-associated protein kinase 70 (ZAP-70), a tyrosine kinase constitutively expressed in T cells, can be found in B cells and is used as a prognostic marker in identifying different forms of chronic lymphocytic leukemia. We previously provided evidence that a subset of B cells in patients with rheumatoid arthritis (RA) expresses ZAP-70, that marks the memory B cell subsets (IgD+CD27+ and IgD-CD27+), thus suggesting that the ZAP-70+ B cells represent a memory activated subset likely involved in the maintenance of an activated B cell pool [1–3]. Objectives: The aim of the present study was to clarify whether B cells, especially ZAP-70 expressing B cells, represent indeed a risk for a severe expression of arthritis in a transgenic ZAP-70+B murine model. Methods: Male transgenic ZAP-70+B mice, that has already been shown to present an high ZAP-70 expression in the B cell lineage [4], aged 8–12 weeks old were used for experiments. All the animals were injected with a cocktail of 5 monoclonal antibodies recognizing the conserved epitopes on various species of type II collagen. Three days later the mice were injected with LPS from E. coli 0111:B4 to trigger arthritis development. Animals were evaluated every 3 days after the infusion of the antibody cocktail for arthritis incidence and each paw was evaluated and scored individually on a scale of 0–4. An arthritis index (AI) that expressed a cumulative score for all paws was calculated for each animal. Results: We found that the transgenic ZAP-70+B cells mice presented a more severe form of arthritis, compared to wild type age-matched mice (p<0.001) (Figure ). Histological and immunohistochemical analyses confirmed the presence of joint erosions and inflammatory infiltrate at the level of the synovium of ZAP-70+B cells mice. Conclusions: These data suggest that B cells amplify the degree of CAIA, that ZAP-70 is involved in the pathogenesis of arthritis in an RA-like model, and that this tyrosine kinase likely represents a possible target of therapy. References: Tolusso B, et al. Clin Immunol. 2009 Apr;131(1):98–108 Michelutti A, et al. Mol Med. 2011 Sep-Oct;17(9–10):901–9 Gremese E, et al. J Rheumatol. 2012 Dec;39(12):2276–85 Gobessi S, et al. Blood (ASH Annual Meeting Abstracts) 2011 118: Abstract 2830? Disclosure of Interest: None declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 75(2016)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 75(2016)Supplement 2
- Issue Display:
- Volume 75, Issue 2 (2016)
- Year:
- 2016
- Volume:
- 75
- Issue:
- 2
- Issue Sort Value:
- 2016-0075-0002-0000
- Page Start:
- 926
- Page End:
- 927
- Publication Date:
- 2016-07-15
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2016-eular.3518 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18372.xml